Dorn J - Search Results

1

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Dorn J, Harbeck N, Kates R, Magdolen V, Grass L, Soosaipillai A, Schmalfeldt B, Diamandis EP, Schmitt M. Dorn J, et al. Biol Chem. 2006 Aug;387(8):1121-8. doi: 10.1515/BC.2006.138. Biol Chem. 2006. PMID: 16895483

2

Human kallikrein 8, a novel biomarker for ovarian carcinoma.

Kishi T, Grass L, Soosaipillai A, Scorilas A, Harbeck N, Schmalfeldt B, Dorn J, Mysliwiec M, Schmitt M, Diamandis EP. Kishi T, et al. Among authors: dorn j. Cancer Res. 2003 Jun 1;63(11):2771-4. Cancer Res. 2003. PMID: 12782581

3

Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.

Yousef GM, Polymeris ME, Grass L, Soosaipillai A, Chan PC, Scorilas A, Borgoño C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP. Yousef GM, et al. Among authors: dorn j. Cancer Res. 2003 Jul 15;63(14):3958-65. Cancer Res. 2003. PMID: 12873991

4

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.

Scorilas A, Borgoño CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP. Scorilas A, et al. Among authors: dorn j. J Clin Oncol. 2004 Feb 15;22(4):678-85. doi: 10.1200/JCO.2004.05.144. J Clin Oncol. 2004. PMID: 14966091

5

Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.

Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. Diamandis EP, et al. Among authors: dorn j. Tumour Biol. 2003 Nov-Dec;24(6):299-309. doi: 10.1159/000076462. Tumour Biol. 2003. PMID: 15004490

6

Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.

Diamandis EP, Borgoño CA, Scorilas A, Harbeck N, Dorn J, Schmitt M. Diamandis EP, et al. Among authors: dorn j. Clin Biochem. 2004 Sep;37(9):823-9. doi: 10.1016/j.clinbiochem.2004.04.009. Clin Biochem. 2004. PMID: 15329323

7

Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.

Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP. Borgoño CA, et al. Among authors: dorn j. Clin Cancer Res. 2006 Mar 1;12(5):1487-93. doi: 10.1158/1078-0432.CCR-05-2106. Clin Cancer Res. 2006. PMID: 16533772

8

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.

Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N. Dorn J, et al. Clin Cancer Res. 2007 Mar 15;13(6):1742-8. doi: 10.1158/1078-0432.CCR-06-2482. Clin Cancer Res. 2007. PMID: 17363527

9

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.

Dorn J, Harbeck N, Kates R, Gkazepis A, Scorilas A, Soosaipillai A, Diamandis E, Kiechle M, Schmalfeldt B, Schmitt M. Dorn J, et al. Ann Oncol. 2011 Apr;22(4):877-883. doi: 10.1093/annonc/mdq462. Epub 2010 Oct 5. Ann Oncol. 2011. PMID: 20924077 Free article.

10

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.

Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M. Dorn J, et al. Ann Oncol. 2011 Aug;22(8):1783-90. doi: 10.1093/annonc/mdq701. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273346 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters